These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15704357

  • 1. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2001 Jul 19; 119 Suppl 2():55-61. PubMed ID: 15704357
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():55-61. PubMed ID: 15700487
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
    Johnston PS, Feig PU, Coniff RF, Krol A, Kelley DE, Mooradian AD.
    Diabetes Care; 1998 Mar 27; 21(3):416-22. PubMed ID: 9540025
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
    Johnston PS, Coniff RF, Hoogwerf BJ, Santiago JV, Pi-Sunyer FX, Krol A.
    Diabetes Care; 1994 Jan 27; 17(1):20-9. PubMed ID: 8112185
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
    Campbell LK, Baker DE, Campbell RK.
    Ann Pharmacother; 2000 Nov 27; 34(11):1291-301. PubMed ID: 11098345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Miglitol combined with metformin improves glycaemic control in type 2 diabetes.
    Van Gaal L, Maislos M, Schernthaner G, Rybka J, Segal P.
    Diabetes Obes Metab; 2001 Oct 27; 3(5):326-31. PubMed ID: 11703422
    [Abstract] [Full Text] [Related]

  • 14. [Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose].
    de Luis Román DA, del Pozo García E, Aller R, Romero Bobillo E, Conde Valentín R.
    Rev Clin Esp; 2004 Jan 27; 204(1):32-4. PubMed ID: 14746760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. alpha-Glucosidase inhibition by miglitol in NIDDM patients.
    Kingma PJ, Menheere PP, Sels JP, Nieuwenhuijzen Kruseman AC.
    Diabetes Care; 1992 Apr 27; 15(4):478-83. PubMed ID: 1499461
    [Abstract] [Full Text] [Related]

  • 18. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.
    Diabetes Obes Metab; 2002 Sep 27; 4(5):329-35. PubMed ID: 12190996
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.
    Schnack C, Prager RJ, Winkler J, Klauser RM, Schneider BG, Schernthaner G.
    Diabetes Care; 1989 Sep 27; 12(8):537-43. PubMed ID: 2673693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.